Literature DB >> 8384246

Sodium-dependent antiporters in choroid plexus epithelial cultures from rabbit.

S E Mayer1, E Sanders-Bush.   

Abstract

The mechanism of recovery from an acid load in primary cultures of rabbit choroid plexus epithelium (CPE) was examined, with emphasis on Na(+)-dependent antiports. Cells were incubated in saline solutions buffered to pH 7.38 with either HEPES or HCO3- plus 95% O2/5% CO2. Intracellular pH (pHi) was determined from the steady-state distribution of [14C]benzoate. Recovery after acidification with NH4Cl was rapid (t1/2 = 5 min) and was dependent on external Na+ (EC50 = 12 mM). Hexamethyleneamiloride and ethylisopropylamiloride, potent inhibitors of the Na+/H+ antiport, blocked 80% of recovery when [Na+] was 5 mM with IC50 values of 100 nM. However, neither drug blocked recovery in normal [Na+]. 4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), an inhibitor of Cl-/HCO3- antiports, blocked recovery of pHi in a dose-related fashion in the presence of bicarbonate, but not in the presence of HEPES. No inhibition occurred with benzamil, an amiloride congener with high affinity for the Na+ channel, nor with dimethylbenzamil, an inhibitor of Na+/Ca2+ exchange. The carbonic anhydrase inhibitor acetazolamide also did not alter recovery from acidification. In CPE that had been pH-clamped with nigericin and KCl, the initial rate of 22Na+ uptake was very rapid (227 pmol/micrograms of DNA/min at pH 6.2), was dependent on external [Na+] with an EC50 value of 8 mM, and was inversely related to the pH of the medium. The maximal inhibition of 22Na+ uptake by hexamethyleneamiloride was 60% with an IC50 value of 76 nM.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384246     DOI: 10.1111/j.1471-4159.1993.tb03291.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  The blood-CSF barrier in culture. Development of a primary culture and transepithelial transport model from choroidal epithelial cells.

Authors:  Wei Zheng; Qiuqu Zhao
Journal:  Methods Mol Biol       Date:  2002

Review 2.  The Glymphatic System: A Beginner's Guide.

Authors:  Nadia Aalling Jessen; Anne Sofie Finmann Munk; Iben Lundgaard; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2015-05-07       Impact factor: 3.996

3.  Primary culture of choroidal epithelial cells: characterization of an in vitro model of blood-CSF barrier.

Authors:  W Zheng; Q Zhao; J H Graziano
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

Review 4.  Molecular mechanisms of cerebrospinal fluid production.

Authors:  P D Brown; S L Davies; T Speake; I D Millar
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 5.  Water and solute secretion by the choroid plexus.

Authors:  Jeppe Praetorius
Journal:  Pflugers Arch       Date:  2006-11-21       Impact factor: 3.657

6.  Culture of choroid plexus epithelial cells and in vitro model of blood-CSF barrier.

Authors:  Andrew D Monnot; Wei Zheng
Journal:  Methods Mol Biol       Date:  2013

7.  Nhe1 is a luminal Na+/H+ exchanger in mouse choroid plexus and is targeted to the basolateral membrane in Ncbe/Nbcn2-null mice.

Authors:  Helle Hasager Damkier; Vikram Prasad; Christian Andreas Hübner; Jeppe Praetorius
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-15       Impact factor: 4.249

8.  Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier.

Authors:  Horace T B Ho; Amber Dahlin; Joanne Wang
Journal:  Front Pharmacol       Date:  2012-08-24       Impact factor: 5.810

9.  Choroid plexus epithelial monolayers--a cell culture model from porcine brain.

Authors:  Carsten Baehr; Valeska Reichel; Gert Fricker
Journal:  Cerebrospinal Fluid Res       Date:  2006-12-21

Review 10.  In Vitro Models of the Blood-Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals.

Authors:  Fatemeh Dabbagh; Horst Schroten; Christian Schwerk
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.